Ferroptosis-centered Disease Response Information
General Information of the Disease (ID: DIS00100)
| Name |
Atherosclerosis
|
||||
|---|---|---|---|---|---|
| ICD |
ICD-11: BD40
|
||||
Full List of Target(s) of This Ferroptosis-centered Disease
Phospholipid hydroperoxide glutathione peroxidase (GPX4)
| In total 2 item(s) under this target | |||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target | [1] | ||||
| Target for Ferroptosis | Suppressor | ||||
| Responsed Disease | Atherosclerosis [ICD-11: BD40] | ||||
| Responsed Drug | Ferric ammonium citrate | Investigative | |||
| Responsed Regulator | NAD-dependent protein deacetylase sirtuin-1 (SIRT1) | Suppressor | |||
| Pathway Response | Autophagy | hsa04140 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell autophagy | |||||
| In Vitro Model | THP-1 cells | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 | |
| In Vivo Model |
A total of 20 male Apoe-/-mice (6-8 weeks of age, 18-22 g) were purchased from Charles River (Beijing, China). Mice were randomly assigned to a control group (normal diet: 4% fat, cholesterol free, and sodium cholate) and an AS group (high-fat diet: 20% fat, 1.25% cholesterol, and 0.5% sodium cholate).
Click to Show/Hide
|
||||
| Response regulation | Ferric ammonium citrate(FAC) can induce a decrease in foam cell activity rather than macrophage activity, increase lipid ROS levels, decrease GPX4 expression and inhibit SIRT1 expression. Activation of SIRT1 can inhibit the ferroptosis and IL-1 and IL-18 levels of foam cells in excess iron by autophagy, providing a novel therapeutic target for atherosclerosis(AS). | ||||
| Experiment 2 Reporting the Ferroptosis-centered Disease Response by This Target | [2] | ||||
| Target for Ferroptosis | Suppressor | ||||
| Responsed Disease | Atherosclerosis [ICD-11: BD40] | ||||
| Responsed Regulator | hsa-mir-132 (Precursor RNA) | Driver | |||
| Pathway Response | Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | ||||
| In Vitro Model | HUVECs (Human umbilical vein endothelial cells) | ||||
| Response regulation | MiR-132 promotes atherosclerosis by inducing mitochondrial oxidative stress-mediated ferroptosis, which may serve as a promising therapeutic target for atherosclerosis. The key iron death protein GPX4 was significantly down-regulated and the oxidized protein NOX4 was significantly increased in miR-132-overexpressing HUVECs (P < 0.001). | ||||
Nuclear factor erythroid 2-related factor 2 (NFE2L2)
| In total 1 item(s) under this target | |||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target | [3] | ||||
| Target for Ferroptosis | Marker/Suppressor | ||||
| Responsed Disease | Atherosclerosis [ICD-11: BD40] | ||||
| Responsed Regulator | All trans-polyprenyl-diphosphate synthase PDSS2 (PDSS2) | Suppressor | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| In Vitro Model | hCAECs (Human coronary artery endothelial cells) | ||||
| In Vivo Model |
Eight-week-old male mice PDSS2 wild type [WT (n = 6)], PDSS2/, Nrf2/, Nrf2+/+, on C57BL/6 background (18-22 g) were provided by Nanjing Medical University (Nanjing, China). PDSS2/ mice (n = 12) were crossed with PDSS2/ to obtain PDSS2/, Nrf2/ (n = 6) and PDSS2/, Nrf2+/+ (n = 6) mice. Mice were fed an AIN76A Western diet for 8 weeks to accelerate the development of AS. Mice from each group were euthanized after 8 weeks.
Click to Show/Hide
|
||||
| Response regulation | Overexpression of PDSS2 suppressed the ferroptosis of HCAECs by promoting the activation of Nrf2 pathways. Thence PDSS2 may play a cardio-protective role in atherosclerosis (AS). | ||||
NADPH oxidase 4 (NOX4)
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response by This Target | [2] | |||
| Target for Ferroptosis | Driver | |||
| Responsed Disease | Atherosclerosis [ICD-11: BD40] | |||
| Responsed Regulator | hsa-mir-132 (Precursor RNA) | Driver | ||
| Pathway Response | Ferroptosis | hsa04216 | ||
| Cell Process | Cell ferroptosis | |||
| In Vitro Model | HUVECs (Human umbilical vein endothelial cells) | |||
| Response regulation | MiR-132 promotes atherosclerosis by inducing mitochondrial oxidative stress-mediated ferroptosis, which may serve as a promising therapeutic target for atherosclerosis. The key iron death protein GPX4 was significantly down-regulated and the oxidized protein NOX4 was significantly increased in miR-132-overexpressing HUVECs (P < 0.001). | |||
References
